Author: Anne Wohlers (1)
Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review.Vet Res 2017 Sep 22;48(1):57. Epub 2017 Sep 22.Joanne Maki, Anne-Laure Guiot, Michel Aubert, Bernard Brochier, Florence Cliquet, Cathleen A Hanlon, Roni King, Ernest H Oertli, Charles E Rupprecht, Caroline Schumacher, Dennis Slate, Boris Yakobson, Anne Wohlers, Emily W Lankau
RABORAL V-RG® is an oral rabies vaccine bait that contains an attenuated ("modified-live") recombinant vaccinia virus vector vaccine expressing the rabies virus glycoprotein gene (V-RG). Approximately 250 million doses have been distributed globally since 1987 without any reports of adverse reactions in wildlife or domestic animals since the first licensed recombinant oral rabies vaccine (ORV) was released into the environment to immunize wildlife populations against rabies. V-RG is genetically stable, is not detected in the oral cavity beyond 48 h after ingestion, is not shed by vaccinates into the environment, and has been tested for thermostability under a range of laboratory and field conditions.
View Full Text PDF Listings View primary source full text article PDFs.